Equal benefits to our residential courses, without the travel.View Courses
All our courses. 12 months access. One flat fee.More Information
Non-members can signup to keep up to date with RQA news and events.Add your details now
EMA’s human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting.
EMA Management Board – highlights of March 2021 meeting Share
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-18 March 2021
In line with current Government advice, the inspectorate will resume an on-site UK risk-based GxP inspection programme from 29 March 2021.
MRC - Identifiability, anonymisation and pseudonymisation article on Guidance note 5.
RSI in Clinical Trials: MHRA Findings and Tips - from Safety Observer
An interesting article written by Harry Mingay and Dr. Rita Hendricusdottir on the classification of IVD devices taken from Oxford Global Guidance.
ABOUT THE ECF REQUIREMENTS: The eClinical Forum has produced a set of Requirements, which are based upon statements in regulatory documents that pertain to the design, development, implementation, and management of electronic systems that support clinical research data as well as those statements that pertain to the handling of data that will be used in a regulated clinical trial. We have reviewed regulatory documents from the FDA, EMA, PMDA, NMPA and ICH to produce this set of requirements. Each Requirement has as its basis one or more statements from one or more of these regulatory documents. The Requirements can be used to determine if systems that data which will become part of a regulated clinical trial are consistent with regulatory requirements and if systems and process that manage these data have the necessary features.
EMA is pleased to announce a “Veterinary Big Data Stakeholder Forum” to be held virtually on 1-2 June 2021.
MHRA have published Pharmacovigilance inspection metrics April 2019 to March 2020.